When validating automated systems from third-party providers, using the V model and failure modes effects and criticality analysis (FMECA) early in the process can help.
Peter Woods
Advertisement
Peter Woods is Programme manager at GB Innomech Ltd (UK).
Articles by Peter Woods
Advertisement
Latest Updated Articles
The benefits of risk-based analyses during system validationPublished: September 1st 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
3
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
4
Turning Real-World Data into Actionable Drug Development Insights With AI
5
